Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Xencor renegotiates XmAb5871 agreement with Amgen Xencor, a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, has regained all development and commercial rights to XmAb 5871 by seeking and obtaining a termination of the prior option and collaboration agreement and executing a new right-of-first-negotiation agreement with Amgen.
Contract Research & Services > Contract Services > News
Iroko signs licensing deal with Aspen to market Zorvolex in Australia and New Zealand By PBR Staff Writer
Iroko Pharmaceuticals has signed a licensing deal with Aspen Pharma to gain exclusive rights to market and sell Zorvolex (diclofenac) capsules in Australia and New Zealand.
Contract Research & Services > Contract Services > News Bristol-Myers Squibb signs $475m option agreement to acquire F-star and FS102 By PBR Staff Writer
Bristol-Myers Squibb (BMS) has signed an exclusive option agreement for about $475m to acquire F-star Alpha and secure worldwide rights to its lead asset and first clinical compound FS102, a new Phase I ready Human Epidermal growth factor Receptor 2 (HER2)-targeted therapy.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Molnár-Institute - DryLab HPLC Method Development Software
Founded in 1981, Molnár-Institute focuses on strategies for improving the efficiency and success of modern HPLC. Our state-of-the-art HPLC modelling software, DryLab supports chromatographers worldwide in method development, optimisation, troubleshooting, robustness testing, and training.
Contract Research & Services > Contract Services > Suppliers
Mersana, Takeda enter commercial license deal for new Fleximer antibody-drug conjugate
Mersana Therapeutics has announced that Millennium Pharmaceuticals, a wholly-owned subsidiary of Takeda Pharmaceutical Company, has exercised an option to license commercial rights for its first novel Fleximer antibody-drug conjugate (ADC) developed under their collaboration announced earlier this year.
Contract Research & Services > Contract Services > News
Medivation licenses anti-PD-1 immune modulatory monoclonal antibody from CureTech
Medivation, and CureTech, announced Medivation has licensed exclusive worldwide rights to CureTech's late-stage clinical molecule pidilizumab (CT-011), an immune modulatory anti-PD-1 monoclonal antibody.
Contract Research & Services > Contract Services > News
Iroko inks new licensing deal with Landsteiner Scientific to market Zorvolex in Mexico
By PBR Staff Writer
Iroko Pharmaceuticals has signed a licensing agreement with Landsteiner Scientific for the exclusive rights to market and sell Zorvolex (diclofenac) capsules in Mexico.
Contract Research & Services > Contract Services > News
NewLink, Genentech ink licensing deal for development of NLG919
By PBR Staff Writer
US-based biopharmaceutical firm NewLink Genetics has entered into an exclusive worldwide license agreement with Genentech, a member of the Roche, to develop its IDO pathway inhibitor NLG919.
Contract Research & Services > Contract Services > News
Enanta Pharmaceuticals provides update on its collaboration agreement with AbbVie
Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, has announced that it has decided not to exercise its co-development option for ABT-493, Enanta’s next-generation protease inhibitor for hepatitis C virus (HCV) being developed in Enanta’s collaboration with AbbVie.
Contract Research & Services > Contract Services > News
DKSH to offer market expansion services for Roche's products across Asia
By PBR Staff Writer
DKSH Business Unit Healthcare has extended its relationship to offer market expansion services for Roche's full pharmaceutical product portfolio in Cambodia, Hong Kong, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam.
Contract Research & Services > Contract Services > News
Batu Biologics gets license from California University for cancer drug
Batu Biologics, an immunotherapy company developing an anti-angiogenic cancer vaccine, announced the signing of a license agreement with the Regents of the University of California, granting exclusive rights to novel peptide drugs developed at UC San Diego that have been proven to stimulate cancer-killing immune responses.
Contract Research & Services > Contract Services > News
Selecta, JDRF and Sanofi to develop SVP immunotherapy for type 1 diabetes
By PBR Staff Writer
Selecta Biosciences and JDRF have extended their joint research collaboration and added Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle (SVP) immunotherapy for the treatment and prevention of the underlying cause of type 1 diabetes.
Contract Research & Services > Contract Services > News
Sucampo extends license, collaboration agreement with Takeda for Amitiza
By PBR Staff Writer
US-based Sucampo Pharmaceuticals has signed an amendment to the existing collaboration and license agreement with Takeda Pharmaceutical Company (Takeda) covering the US and Canada for Amitiza (lubiprostone).
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250